Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles

• 收藏
• 分享

专利权人:

Basilea Pharmaceutica AG

发明人:

Lane, Heidi Alexandra,Bachmann, Felix

申请号：

AU2012208516

公开号：

AU2012208516B2

申请日:

2012.01.19

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

Use of glu-tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazole compound of general formula (I).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/